- Services
- Cytopathology
- Histopathology
- Instruments
- Slide Strainer
- Tissue Processor
- Microtomes
- Consumables
- Antibodies
- Reagents
Anatomic Pathology Market size was valued at USD 19,739.5 million in 2023 and is poised to grow at a significant CAGR of 8.3% from 2024-2030. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the Anatomic Pathology Market report includes human demographics regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. The anatomic pathology is a branch of science that involves in molecular, biochemical and microscopic analysis of tissues and organs in order to find the effectiveness of diseases. The main objective of anatomic pathology is the identification of abnormalities to manage treatment and diagnosis. This can be helpful diagnosis of different types of cancers. The global anatomic pathology market is surging owing to frequent acquisitions and collaborations by the market players. For instance, In November 2018, Quest Diagnostics, Inc. agreed to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories or BBPL including anatomic pathology services. Moreover, In December 2018, Sonic Healthcare acquired Aurora Diagnostics to expand its anatomic pathology services in U.S.
Anatomic Pathology Market Summary
Study Period
2024-2030Base Year
2023CAGR
8.3%Largest Market
Asia PacificFastest Growing Market
North AmericaAnatomic Pathology Market Dynamics
Anatomic Pathology market is driven by growing prevalence of chronic disease, increase in geriatric population, rise in initiatives taken by the government in order to prevent the diseases. Furthermore, rise in incidence of STD’s, changes in lifestyle of people, increase in awareness regarding diseases and their preventive measures are expected to propel the growth of the market. On the other hand, lack of awareness in developing countries, high cost of the process are dampen the anatomic pathology market.Based on end-user, hospitals accounted for larger market revenue share and projected gain market revenue share over the forecast period. Players focusing on innovation of newer products and collaboration strategies to retain market position in global anatomic pathology market
North-America Got Significant Share
Anatomic Pathology Market Regional Analysis
Geographically Anatomic Pathology Market is segmented as Latin America, Europe, Asia Pacific, North America, and Middle East and Africa. North America is expected to remain the dominant market in global anatomic pathology market throughout the forecast period, followed by Europe due to more number of players are expected to enter into the former market during the forecast period. Japan is expected to be the next lucrative market for companies, and the market is estimated to register good revenue over the forecast period. Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to rising penetration of the digital imaging in emerging economies, growing investments in medical field, and the presence of untapped opportunities. Asia Pacific healthcare industry has highly influenced the anatomic pathology due to increased incidence of cancer, geriatric population pool. Increasing demand for novel treatment options, better patient care facilities, and reduction in laboratory expenses are expected to drive demand in the coming years.
Latin America
Europe
Asia Pacific
Middle East
North America
Anatomic Pathology Market Segmentation
By Product
By Application
- Drug Discovery
- Diagnosis
By End User
- Hospitals
- Research Organization
- Diagnostic Centres
By Geography
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Frequently Asked Questions
The anatomic pathology market size was valued at USD 19,739.5 million in 2023
The anatomic pathology market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA
The anatomic pathology market key players Thermo Fisher Scientific (U.S.), Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Agilent Technologies (U.S.), Quest Diagnostics Incorporated (U.S.), NeoGenomics Laboratories, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.)
Key Features of the Report
- The anatomic pathology market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
| 1.Executive Summary |
| 2.Global Anatomic Pathology Market Introduction |
| 2.1.Global Anatomic Pathology Market - Taxonomy |
| 2.2.Global Anatomic Pathology Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Anatomic Pathology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Anatomic Pathology Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Anatomic Pathology Market By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Services |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Consumables |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Anatomic Pathology Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Drug Discovery |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Diagnosis |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Anatomic Pathology Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Research Organization |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Centres |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Anatomic Pathology Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Services |
| 9.1.2.Instruments |
| 9.1.3.Consumables |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Drug Discovery |
| 9.2.2.Diagnosis |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Research Organization |
| 9.3.3.Diagnostic Centres |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Services |
| 10.1.2.Instruments |
| 10.1.3.Consumables |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Drug Discovery |
| 10.2.2.Diagnosis |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Research Organization |
| 10.3.3.Diagnostic Centres |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Services |
| 11.1.2.Instruments |
| 11.1.3.Consumables |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Drug Discovery |
| 11.2.2.Diagnosis |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Research Organization |
| 11.3.3.Diagnostic Centres |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Services |
| 12.1.2.Instruments |
| 12.1.3.Consumables |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Drug Discovery |
| 12.2.2.Diagnosis |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Research Organization |
| 12.3.3.Diagnostic Centres |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Anatomic Pathology Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Services |
| 13.1.2.Instruments |
| 13.1.3.Consumables |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Drug Discovery |
| 13.2.2.Diagnosis |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Research Organization |
| 13.3.3.Diagnostic Centres |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Thermo Fisher Scientific (U.S.) |
| 14.2.2.Hoffmann-La Roche AG (Switzerland) |
| 14.2.3.Danaher Corporation (U.S.) |
| 14.2.4.Sakura Finetechnical Co., Ltd. (Japan) |
| 14.2.5.Agilent Technologies (U.S.) |
| 14.2.6.Quest Diagnostics Incorporated (U.S.) |
| 14.2.7.NeoGenomics Laboratories, Inc. (U.S.) |
| 14.2.8.Laboratory Corporation of America Holdings (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Thermo Fisher Scientific (U.S.)
- Hoffmann-La Roche AG (Switzerland)
- Danaher Corporation (U.S.)
- Sakura Finetechnical Co., Ltd. (Japan)
- Agilent Technologies (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- NeoGenomics Laboratories, Inc. (U.S.)
- Laboratory Corporation of America Holdings (U.S.)